Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty(Ⓡ)])

The messenger RNA vaccine against SARS-CoV-2 is effective at preventing COVID-19-associated hospitalization, and the Centers for Disease Control and Prevention has recommended vaccination for all eligible individuals. We demonstrate a case involving a patient who developed a life-threatening acute a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Masaru, Satonaga, Yoshio, Takaki, Ryuichiro, Yabe, Michitoshi, Kan, Takamasa, Omote, Erika, Yamasaki, Toru, Komiya, Kosaku, Hiramatsu, Kazufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477784/
https://www.ncbi.nlm.nih.gov/pubmed/36122668
http://dx.doi.org/10.1016/j.ijid.2022.09.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477784/
https://www.ncbi.nlm.nih.gov/pubmed/36122668
http://dx.doi.org/10.1016/j.ijid.2022.09.019

Ejemplares similares